161 related articles for article (PubMed ID: 24530938)
1. Does the HPV vaccination programme have implications for cervical screening programmes in the UK?
Beer H; Hibbitts S; Brophy S; Rahman MA; Waller J; Paranjothy S
Vaccine; 2014 Apr; 32(16):1828-33. PubMed ID: 24530938
[TBL] [Abstract][Full Text] [Related]
2. The impact of bivalent HPV vaccine on cervical intraepithelial neoplasia by deprivation in Scotland: reducing the gap.
Cameron RL; Kavanagh K; Cameron Watt D; Robertson C; Cuschieri K; Ahmed S; Pollock KG
J Epidemiol Community Health; 2017 Oct; 71(10):954-960. PubMed ID: 28756395
[TBL] [Abstract][Full Text] [Related]
3. Equity in human papilloma virus vaccination uptake?: sexual behaviour, knowledge and demographics in a cross-sectional study in (un)vaccinated girls in the Netherlands.
Mollers M; Lubbers K; Spoelstra SK; Weijmar-Schultz WC; Daemen T; Westra TA; van der Sande MA; Nijman HW; de Melker HE; Tami A
BMC Public Health; 2014 Mar; 14():288. PubMed ID: 24679163
[TBL] [Abstract][Full Text] [Related]
4. Opportunistic HPV vaccination at age 16-23 and cervical screening attendance in Sweden: a national register-based cohort study.
Kreusch T; Wang J; Sparén P; Sundström K
BMJ Open; 2018 Oct; 8(10):e024477. PubMed ID: 30282687
[TBL] [Abstract][Full Text] [Related]
5. The Participation of HPV-Vaccinated Women in a National Cervical Screening Program: Population-Based Cohort Study.
Herweijer E; Feldman AL; Ploner A; Arnheim-Dahlström L; Uhnoo I; Netterlid E; Dillner J; Sparén P; Sundström K
PLoS One; 2015; 10(7):e0134185. PubMed ID: 26218492
[TBL] [Abstract][Full Text] [Related]
6. Effect of human papillomavirus vaccination on cervical cancer screening in Alberta.
Kim J; Bell C; Sun M; Kliewer G; Xu L; McInerney M; Svenson LW; Yang H
CMAJ; 2016 Sep; 188(12):E281-E288. PubMed ID: 27378467
[TBL] [Abstract][Full Text] [Related]
7. The projected timeframe until cervical cancer elimination in Australia: a modelling study.
Hall MT; Simms KT; Lew JB; Smith MA; Brotherton JM; Saville M; Frazer IH; Canfell K
Lancet Public Health; 2019 Jan; 4(1):e19-e27. PubMed ID: 30291040
[TBL] [Abstract][Full Text] [Related]
8. Primary HPV testing versus cytology-based cervical screening in women in Australia vaccinated for HPV and unvaccinated: effectiveness and economic assessment for the National Cervical Screening Program.
Lew JB; Simms KT; Smith MA; Hall M; Kang YJ; Xu XM; Caruana M; Velentzis LS; Bessell T; Saville M; Hammond I; Canfell K
Lancet Public Health; 2017 Feb; 2(2):e96-e107. PubMed ID: 29253402
[TBL] [Abstract][Full Text] [Related]
9. Addressing health inequalities in the delivery of the human papillomavirus vaccination programme: examining the role of the school nurse.
Boyce T; Holmes A
PLoS One; 2012; 7(9):e43416. PubMed ID: 23028452
[TBL] [Abstract][Full Text] [Related]
10. Prediction of cervical cancer incidence in England, UK, up to 2040, under four scenarios: a modelling study.
Castanon A; Landy R; Pesola F; Windridge P; Sasieni P
Lancet Public Health; 2018 Jan; 3(1):e34-e43. PubMed ID: 29307386
[TBL] [Abstract][Full Text] [Related]
11. "I thought cancer was one of those random things. I didn't know cancer could be caught...": adolescent girls' understandings and experiences of the HPV programme in the UK.
Hilton S; Smith E
Vaccine; 2011 Jun; 29(26):4409-15. PubMed ID: 21514348
[TBL] [Abstract][Full Text] [Related]
12. Mothers' screening histories influence daughters' vaccination uptake: an analysis of linked cervical screening and human papillomavirus vaccination records in the North West of England.
Spencer Nee Pilkington AM; Brabin L; Verma A; Roberts SA
Eur J Cancer; 2013 Apr; 49(6):1264-72. PubMed ID: 23290788
[TBL] [Abstract][Full Text] [Related]
13. Exacerbating disparities?: Cervical cancer screening and HPV vaccination.
Silver MI; Kobrin S
Prev Med; 2020 Jan; 130():105902. PubMed ID: 31730943
[TBL] [Abstract][Full Text] [Related]
14. Impact of a population-based HPV vaccination program on cervical abnormalities: a data linkage study.
Gertig DM; Brotherton JM; Budd AC; Drennan K; Chappell G; Saville AM
BMC Med; 2013 Oct; 11():227. PubMed ID: 24148310
[TBL] [Abstract][Full Text] [Related]
15. How does HPV vaccination status relate to risk perceptions and intention to participate in cervical screening? a survey study.
Hestbech MS; Gyrd-Hansen D; Kragstrup J; Siersma V; Brodersen J
BMC Public Health; 2016 Aug; 15():708. PubMed ID: 27488178
[TBL] [Abstract][Full Text] [Related]
16. Sociodemographic factors predicting mother's cervical screening and daughter's HPV vaccination uptake.
Spencer AM; Roberts SA; Brabin L; Patnick J; Verma A
J Epidemiol Community Health; 2014 Jun; 68(6):571-7. PubMed ID: 24567443
[TBL] [Abstract][Full Text] [Related]
17. HPV immunisation and increased uptake of cervical screening in Scottish women; observational study of routinely collected national data.
Palmer TJ; McFadden M; Pollock KG; Kavanagh K; Cuschieri K; Cruickshank M; Nicoll S; Robertson C
Br J Cancer; 2016 Mar; 114(5):576-81. PubMed ID: 26794278
[TBL] [Abstract][Full Text] [Related]
18. Cervical cancer screening rate differs by HPV vaccination status: An interim analysis.
Taniguchi M; Ueda Y; Yagi A; Ikeda S; Endo M; Tomimatsu T; Nakayama T; Sekine M; Enomoto T; Kimura T
Vaccine; 2019 Jul; 37(32):4424-4426. PubMed ID: 31272873
[TBL] [Abstract][Full Text] [Related]
19. Human papillomavirus vaccine effectiveness within a cervical cancer screening programme: cohort study.
Acuti Martellucci C; Nomura S; Yoneoka D; Ueda P; Brotherton J; Canfell K; Palmer M; Manzoli L; Giorgi Rossi P; De Togni A; Palmonari C; Califano A; Saito E; Hashizume M; Shibuya K
BJOG; 2021 Feb; 128(3):532-539. PubMed ID: 32779381
[TBL] [Abstract][Full Text] [Related]
20. Coverage of the English national human papillomavirus (HPV) immunisation programme among 12 to 17 year-old females by area-level deprivation score, England, 2008 to 2011.
Hughes A; Mesher D; White J; Soldan K
Euro Surveill; 2014 Jan; 19(2):. PubMed ID: 24457007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
